middle.news
Cyclopharm Raises A$16M to Accelerate US Technegas Rollout and Beyond PE Growth
9:50am on Wednesday 4th of February, 2026 AEDT
•
Healthcare
Read Story
Cyclopharm Raises A$16M to Accelerate US Technegas Rollout and Beyond PE Growth
9:50am on Wednesday 4th of February, 2026 AEDT
Key Points
A$16 million equity raise via institutional placement and Share Purchase Plan
Record global sales revenue of $32.3 million in 2025, up 17%
Targeting 250-300 US Technegas installations by second half of 2026
Strong US sales growth with 44 active revenue-generating sites
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cyclopharm (ASX:CYC)
OPEN ARTICLE